Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry

A. Froidure (Bruxelles, Belgium), B. Bondue (Bruxelles, Belgium), C. Dahlqvist (Yvoir, Belgium), J. Guiot (Liège, Belgium), N. Gusbin (Liège, Belgium), G. Wirtz (Luxembourg, Luxembourg), G. Joos (Gent, Belgium), D. Strens (Leuven, Belgium), H. Slabbynck (Antwerpen, Belgium), W. Wuyts (Leuven, Belgium)

Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Session: Genetics and translational aspects of idiopathic pulmonary fibrosis
Session type: Oral Presentation
Number: 4328

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Froidure (Bruxelles, Belgium), B. Bondue (Bruxelles, Belgium), C. Dahlqvist (Yvoir, Belgium), J. Guiot (Liège, Belgium), N. Gusbin (Liège, Belgium), G. Wirtz (Luxembourg, Luxembourg), G. Joos (Gent, Belgium), D. Strens (Leuven, Belgium), H. Slabbynck (Antwerpen, Belgium), W. Wuyts (Leuven, Belgium). Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry. 4328

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variants of the clinical course of familial pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019


Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients.
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005

Familial cases of idiopathic pulmonary fibrosis: Clinical observation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry
Source: Eur Respir J 2001; 18: Suppl. 33, 510s
Year: 2001

Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Features of tuberculosis incidence and clinical forms for sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 202s
Year: 2004

Study of IPF relatives as a method of early diagnosis of ILD disease
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Monitoring disease progression in patients with biopsy proven cases of sarcoidosis: A survey
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017



Thyroid disease in an Irish cohort of sarcoidosis patients
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002